Sabine Weiskirchen - Search Results

Year	Number of Results
2003	1
2008	1
2014	1
2015	2
2016	4
2017	3
2018	3
2019	4
2020	5
2021	2

1

Organ and tissue fibrosis: Molecular signals, cellular mechanisms and translational implications.

Weiskirchen R, Weiskirchen S, Tacke F. Weiskirchen R, et al. Among authors: weiskirchen s. Mol Aspects Med. 2019 Feb;65:2-15. doi: 10.1016/j.mam.2018.06.003. Epub 2018 Jun 30. Mol Aspects Med. 2019. PMID: 29958900 Review.

2

Isolation and Culture of Primary Murine Hepatic Stellate Cells.

Weiskirchen S, Tag CG, Sauer-Lehnen S, Tacke F, Weiskirchen R. Weiskirchen S, et al. Methods Mol Biol. 2017;1627:165-191. doi: 10.1007/978-1-4939-7113-8_11. Methods Mol Biol. 2017. PMID: 28836201

3

Resveratrol: How Much Wine Do You Have to Drink to Stay Healthy?

Weiskirchen S, Weiskirchen R. Weiskirchen S, et al. Adv Nutr. 2016 Jul 15;7(4):706-18. doi: 10.3945/an.115.011627. Print 2016 Jul. Adv Nutr. 2016. PMID: 27422505 Free PMC article. Review.

4

Bile duct ligation in mice: induction of inflammatory liver injury and fibrosis by obstructive cholestasis.

Tag CG, Sauer-Lehnen S, Weiskirchen S, Borkham-Kamphorst E, Tolba RH, Tacke F, Weiskirchen R. Tag CG, et al. Among authors: weiskirchen s. J Vis Exp. 2015 Feb 10;(96):52438. doi: 10.3791/52438. J Vis Exp. 2015. PMID: 25741630 Free PMC article.

5

The hepatic lipidome: From basic science to clinical translation.

Ten Hove M, Pater L, Storm G, Weiskirchen S, Weiskirchen R, Lammers T, Bansal R. Ten Hove M, et al. Among authors: weiskirchen s. Adv Drug Deliv Rev. 2020;159:180-197. doi: 10.1016/j.addr.2020.06.027. Epub 2020 Jun 30. Adv Drug Deliv Rev. 2020. PMID: 32615143 Free article. Review.

6

Intrahepatic T_H17/T_Reg Cells in Homeostasis and Disease-It's All About the Balance.

Drescher HK, Bartsch LM, Weiskirchen S, Weiskirchen R. Drescher HK, et al. Among authors: weiskirchen s. Front Pharmacol. 2020 Oct 2;11:588436. doi: 10.3389/fphar.2020.588436. eCollection 2020. Front Pharmacol. 2020. PMID: 33123017 Free PMC article. Review.

7

Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy.

Asimakopoulou A, Weiskirchen S, Weiskirchen R. Asimakopoulou A, et al. Among authors: weiskirchen s. Front Physiol. 2016 Sep 27;7:430. doi: 10.3389/fphys.2016.00430. eCollection 2016. Front Physiol. 2016. PMID: 27729871 Free PMC article. Review.

8

L-Selectin/CD62L is a Key Driver of Non-Alcoholic Steatohepatitis in Mice and Men.

Drescher HK, Schippers A, Rosenhain S, Gremse F, Bongiovanni L, Bruin A, Eswaran S, Gallage SU, Pfister D, Szydlowska M, Heikenwalder M, Weiskirchen S, Wagner N, Trautwein C, Weiskirchen R, Kroy DC. Drescher HK, et al. Among authors: weiskirchen s. Cells. 2020 Apr 29;9(5):1106. doi: 10.3390/cells9051106. Cells. 2020. PMID: 32365632 Free PMC article.

9

Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH).

Drescher HK, Weiskirchen S, Weiskirchen R. Drescher HK, et al. Among authors: weiskirchen s. Cells. 2019 Aug 7;8(8):845. doi: 10.3390/cells8080845. Cells. 2019. PMID: 31394730 Free PMC article. Review.

10

Cellular Mechanisms of Liver Fibrosis.

Acharya P, Chouhan K, Weiskirchen S, Weiskirchen R. Acharya P, et al. Among authors: weiskirchen s. Front Pharmacol. 2021 May 6;12:671640. doi: 10.3389/fphar.2021.671640. eCollection 2021. Front Pharmacol. 2021. PMID: 34025430 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results